Is Takeda Pharmaceutical Company Limited (TAK) Facing Major Legal Risk After U.S. Jury Rules on Generic Drug Delay?

Otsuka showcases kidney drug data; Pfizer cuts an AI deal

Adlib Appoints Kristen Sauter as President & GM of Life Sciences to Accelerate Its Vertical AI Strategy

GSK, Takeda and others notch key clinical wins in tough-to-treat diseases

EVERSANA Strengthens Commitment to Driving Market Access Growth with Addition of Industry Expert Jen Norton

U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn's Disease

Alkermes Touts Orexin Ambitions as Alixorexton Enters Phase 3 and CEO Transition Nears

Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test

Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations

Takeda Designed A Psoriasis Pill Using AI. It Just Walloped Bristol's Sotyktu In A Head-To-Head Test.